BioCentury | Feb 2, 2021
Management Tracks

Merck vet Drouet joining CRISPR; plus updates from Cerevance, Rinri, MOMA, Vivoryon, Kadimastem

...Ltd. appointed Nick Higgins as chairman, succeeding Erica Whittaker. Higgins was CEO of cell therapy company Intercytex...
BioCentury | Dec 12, 2011
Company News

Altrika Ltd., Asymptote Ltd., Cell Medica, CellSeed, Cellzome, ImmunoSolv, Intercytex, Kirkstall, Lonza, Neotherix, Orthox, Plasticell, Stabilitech, TAP Biosyst

...CellSeed Inc. (JASDAQ:7776), Tokyo, Japan Cellzome AG , Heidelberg, Germany ImmunoSolv Ltd. , Edinburgh, U.K. Intercytex Ltd....
BioCentury | Dec 6, 2011
Company News

U.K. awards $13.3 million for regenerative medicine

...Medica Ltd. (London, U.K.), CellSeed Inc. (JASDAQ:7776), Cellzome AG (Heidelberg, Germany), ImmunoSolv Ltd. (Edinburgh, U.K.), Intercytex Ltd....
BioCentury | Mar 21, 2011
Clinical News

Vavelta: Phase II started

...receive 0.25 mL of 20 x10 6 cells/mL ICX-RHY per linear cm of erosion margin. Intercytex...
BioCentury | Apr 26, 2010
Company News

Silence Therapeutics management update

...Business: Cancer, Renal, Ophthalmic Hired: Max Herrmann as CFO, effective May 4; formerly CFO of Intercytex...
BioCentury | Jan 25, 2010
Company News

Healthpoint, Intercytex Group plc deal

...Healthpoint acquired Cyzact (ICX-PRO) and ICX-SKN from Intercytex. Cyzact is a second-generation allogeneic human dermal fibroblast...
...trial to treat acute wounds via skin graft. Further terms were not disclosed. In 2009, Intercytex...
...see BioCentury, April 6, 2009 & Dec. 7, 2009). Healthpoint Ltd. , Fort Worth, Texas Intercytex...
BioCentury | Dec 14, 2009
Financial News

Intercytex financial update

...share cancellation and name change are contingent on shareholder approval at a Dec. 23 meeting. Intercytex...
BioCentury | Dec 7, 2009
Company News

Intercytex Group plc, Pfizer deal

...Pfizer acquired undisclosed stem cell therapy assets from Intercytex's Axordia Ltd. subsidiary for $750,000. Intercytex will...
...and said it had received offers to acquire undisclosed parts of the business. In March, Intercytex...
...and plans to complete divestment of all assets by year end. At Dec. 31, 2008, Intercytex...
BioCentury | Oct 5, 2009
Finance

Restructuring Watch

...and conserving cash; restructured twice last year to focus on research and partnering products 7/1/09 Intercytex...
BioCentury | Sep 7, 2009
Financial News

Intercytex financial update

...its interim financial results. Intercytex said delay is a result of its ongoing divestment process. Intercytex...
Items per page:
1 - 10 of 58
BioCentury | Feb 2, 2021
Management Tracks

Merck vet Drouet joining CRISPR; plus updates from Cerevance, Rinri, MOMA, Vivoryon, Kadimastem

...Ltd. appointed Nick Higgins as chairman, succeeding Erica Whittaker. Higgins was CEO of cell therapy company Intercytex...
BioCentury | Dec 12, 2011
Company News

Altrika Ltd., Asymptote Ltd., Cell Medica, CellSeed, Cellzome, ImmunoSolv, Intercytex, Kirkstall, Lonza, Neotherix, Orthox, Plasticell, Stabilitech, TAP Biosyst

...CellSeed Inc. (JASDAQ:7776), Tokyo, Japan Cellzome AG , Heidelberg, Germany ImmunoSolv Ltd. , Edinburgh, U.K. Intercytex Ltd....
BioCentury | Dec 6, 2011
Company News

U.K. awards $13.3 million for regenerative medicine

...Medica Ltd. (London, U.K.), CellSeed Inc. (JASDAQ:7776), Cellzome AG (Heidelberg, Germany), ImmunoSolv Ltd. (Edinburgh, U.K.), Intercytex Ltd....
BioCentury | Mar 21, 2011
Clinical News

Vavelta: Phase II started

...receive 0.25 mL of 20 x10 6 cells/mL ICX-RHY per linear cm of erosion margin. Intercytex...
BioCentury | Apr 26, 2010
Company News

Silence Therapeutics management update

...Business: Cancer, Renal, Ophthalmic Hired: Max Herrmann as CFO, effective May 4; formerly CFO of Intercytex...
BioCentury | Jan 25, 2010
Company News

Healthpoint, Intercytex Group plc deal

...Healthpoint acquired Cyzact (ICX-PRO) and ICX-SKN from Intercytex. Cyzact is a second-generation allogeneic human dermal fibroblast...
...trial to treat acute wounds via skin graft. Further terms were not disclosed. In 2009, Intercytex...
...see BioCentury, April 6, 2009 & Dec. 7, 2009). Healthpoint Ltd. , Fort Worth, Texas Intercytex...
BioCentury | Dec 14, 2009
Financial News

Intercytex financial update

...share cancellation and name change are contingent on shareholder approval at a Dec. 23 meeting. Intercytex...
BioCentury | Dec 7, 2009
Company News

Intercytex Group plc, Pfizer deal

...Pfizer acquired undisclosed stem cell therapy assets from Intercytex's Axordia Ltd. subsidiary for $750,000. Intercytex will...
...and said it had received offers to acquire undisclosed parts of the business. In March, Intercytex...
...and plans to complete divestment of all assets by year end. At Dec. 31, 2008, Intercytex...
BioCentury | Oct 5, 2009
Finance

Restructuring Watch

...and conserving cash; restructured twice last year to focus on research and partnering products 7/1/09 Intercytex...
BioCentury | Sep 7, 2009
Financial News

Intercytex financial update

...its interim financial results. Intercytex said delay is a result of its ongoing divestment process. Intercytex...
Items per page:
1 - 10 of 58